Goal 2: Reduce Human Disease

Drug Desensitization Protocols

As the current chair of the Research and Training Division, I would like to convey that the AAAAI membership would like the NHLBI to consider the following in the development of its strategic plan:


Given that increasing number of patients allergic to their best medications are treated with desensitization, which allows improved quality of life and prolongs their lives,  what  personalized, effective and safe protocols will be available to provide first line therapies to these patients?  

Tags (Keywords associated with the idea)


-9 net votes
4 up votes
13 down votes
Idea No. 467